Clinical Trials Browser

Adenocarcinoma, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Breast Diseases, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Genital Diseases, Male, Intestinal Neoplasms, Kidney Diseases, Kidney Neoplasms, Melanoma, Neoplasms, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Prostatic Diseases, Prostatic Neoplasms, Skin Diseases, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms, Colorectal Neoplasms, Neuroectodermal Tumors, Nevi and Melanomas, Neuroendocrine Tumors

NCT00894647 2010-08-31

Safety and Effectiveness Study of Actinic Keratosis Treatment Following Cryosurgery

Phase 3 Completed

247 enrolled 11 charts

Dermatologic

Skin Diseases, Keratosis, Actinic

NCT00603798 2010-06-29

Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs)

Phase 3 Completed

490 enrolled 12 charts

Dermatologic

Skin Diseases, Keratosis, Actinic

NCT00605176 2010-06-29

Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs)

Phase 3 Completed

479 enrolled 12 charts

Dermatologic

Skin Diseases, Keratosis, Actinic

Clinical Trials

COLUMBUS

Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp

VISION

AK003

Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma

Mel55

A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)

Safety and Effectiveness Study of Actinic Keratosis Treatment Following Cryosurgery

Safety and Effectiveness Study of Imiquimod Creams for the Treatment of Actinic Keratoses (AKs)

Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs)